This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Medical Properties' (MPW) Q1 Earnings?
by Zacks Equity Research
While Medical Properties (MPW) will likely benefit from an aging demographic, high tenant concentration may lend volatility to its bottom-line growth in the first quarter.
Medical Properties (MPW) Meets Q4 FFO Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 0.00% and -3.89%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Liberty Property (LPT) Q4 FFO Tops, Gives Sears Impact Update
by Zacks Equity Research
Liberty Property's (LPT) Q4 results highlight rent escalation in industrial portfolio. It plans an aggressive push toward concluding its repositioning efforts and issued the Sears bankruptcy impact.
Digital Realty (DLR) Q4 FFO Tops Estimates, Revenues Up Y/Y
by Zacks Equity Research
Digital Realty Trust's (DLR) Q4 results highlight decent demand for data-center facilities, encouraging the company to reaffirm its core FFO projections for the current year.
Alexandria (ARE) Q4 FFO & Revenues Miss Estimates, Up Y/Y
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) Q4 results highlight increase in rental rate. However, expenses tied to rental operations and interests were higher in the quarter.
Key Factors to Impact Medical Properties' (MPW) Q4 Earnings
by Zacks Equity Research
While Medical Properties (MPW) will likely benefit from favorable trends in the healthcare sector, rising interest rates might impede bottom-line growth in the fourth quarter.
Medical Properties (MPW) Beats Q3 FFO and Revenue Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of 2.94% and 0.06%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Q2 Earnings Meet Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered earnings and revenue surprises of 0.00% and -2.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
CBRE Group (CBRE) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
CBRE Group's (CBRE) Q2 results likely to reflect strength across its global regions and growth in global occupier outsourcing business.
This Week's Growth & Income Stock: Medical Properties Trust (MPW)
by Jeremy Mullin
Growth & Income Stock Strategist, Todd Bunton, CFA, highlights Medical Properties Trust (MPW) on April 2, 2015.